Author:
Simulundu Edgar,Mupeta Francis,Chanda-Kapata Pascalina,Saasa Ngonda,Changula Katendi,Muleya Walter,Chitanga Simbarashe,Mwanza Miniva,Simusika Paul,Chambaro Herman,Mubemba Benjamin,Kajihara Masahiro,Chanda Duncan,Mulenga Lloyd,Fwoloshi Sombo,Shibemba Aaron Lunda,Kapaya Fred,Zulu Paul,Musonda Kunda,Monze Mwaka,Sinyange Nyambe,Mazaba Mazyanga L.,Kapin’a Muzala,Chipimo Peter J.,Hamoonga Raymond,Simwaba Davie,Ngosa William,Morales Albertina N.,Kayeyi Nkomba,Tembo John,Bates Mathew,Orba Yasuko,Sawa Hirofumi,Takada Ayato,Nalubamba King S.,Malama Kennedy,Mukonka Victor,Zumla Alimuddin,Kapata Nathan
Funder
European and Developing Countries Clinical Trials Partnership
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference25 articles.
1. SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate;Becerra-Flores;Int J Clin Pract,2020
2. Main routes of entry and genomic diversity of SARS-CoV-2, Uganda;Bugembe;Emerg Infect Dis,2020
3. CDC 2020. Interim guidelines for collecting, handling, and testing clinical specimens from persons under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV). https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html. [Accessed 8 April 2020].
4. Seroprevalence of filovirus infection of Rousettus aegyptiacus bats in Zambia;Changula;J Infect Dis,2018
5. Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study;Gilbert;Lancet,2020